Additional studies were conducted by Li et al., who demonstrated that TWIST1 was highly upregulated in cisplatin-resistant ovarian cancer cells as compared to cisplatin-sensitive cells [81]. This evidence concerns the gene TWIST1 and ovarian carcinoma.